Cargando…
Cyclooxygenase-2 activates EGFR–ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia
OBJECTIVE AND DESIGN: Prostatic inflammation is the driving force in benign prostatic hyperplasia (BPH). This work investigated the potential modulatory effect of COX-2 inhibition on ADAM-17/EGFR/ERK1/2 axis. MATERIALS OR SUBJECTS: Adult male Wistar rats were used. TREATMENT: Celecoxib (10 and 20 mg...
Autores principales: | Abo-El Fetoh, Mohammed E., Abdel-Fattah, Maha M., Mohamed, Wafaa R., Ramadan, Laila A. A., Afify, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958186/ https://www.ncbi.nlm.nih.gov/pubmed/36586043 http://dx.doi.org/10.1007/s10787-022-01123-7 |
Ejemplares similares
-
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Inflammatory Cyclooxygenase Activity and PGE(2) Signaling in Models of Alzheimer’s Disease
por: Johansson, Jenny U., et al.
Publicado: (2015) -
The influence of environmental and core temperature on cyclooxygenase and PGE2 in healthy humans
por: Esh, Christopher J., et al.
Publicado: (2021) -
Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas
por: Akbari, Nasrin, et al.
Publicado: (2020) -
Cyclooxygenase-2 Overexpression in Chronic Inflammation Associated with Benign Prostatic Hyperplasia: Is It Related to Apoptosis and Angiogenesis of Prostate Cancer?
por: Kim, Byung Hoon, et al.
Publicado: (2011)